Treating refractory obsessive-compulsive disorder with transcranial direct current stimulation: An open label study
- PMID: 32406608
- PMCID: PMC7375126
- DOI: 10.1002/brb3.1648
Treating refractory obsessive-compulsive disorder with transcranial direct current stimulation: An open label study
Abstract
Background: Obsessive-compulsive disorder (OCD) is a complex disorder with 40%-60% of patients' refractory to treatment. Transcranial direct current stimulation (tDCS) has been shown to induce potent and long-lasting effects on cortical excitability. The aim of the present clinical trial was to evaluate the therapeutic efficacy and tolerability of cathodal tDCS over the supplementary motor area (SMA) in treatment-resistant OCD patients.
Methods: Twenty-one treatment-resistant OCD outpatients received 10 sessions of tDCS. Each treatment session consisted of 2 mA stimuli for 30 min. The cathode was positioned over the bilateral SMA and the anode over the right supraorbital area. Patients were evaluated at baseline, end of treatment, one-month follow-up, and three-month follow-up. Response to treatment was defined as at least a decrease of 35% on the Yale-Brown Obsessive-Compulsive Scale (YBOCS) and a score of 2 or less on the Clinical Global Impressions-Improvement (CGI-I) between baseline and 1-month follow-up.
Results: There was a significant decrease of YBOCS scores between baseline and one-month assessment. At one month, five patients (24%) were considered as responders and 3 (15%) at 3 months. We also observed concomitant changes in depressive symptoms, and insight. The treatment was well tolerated. Short-lasting side effects were reported as localized tingling sensation and skin redness.
Conclusion: Our results suggest that the use of cathodal tDCS over the SMA and anodal tDCS over the right supraorbital area in OCD treatment-refractory patients is safe and promising to improve obsessive and compulsive symptoms. Large randomized controlled trials are needed to confirm this positive result.
Keywords: obsessive-compulsive disorder; supplementary motor area; tDCS; treatment.
© 2020 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest related to this study.
Figures
Similar articles
-
Comparing Different Montages of Transcranial Direct Current Stimulation in Treating Treatment-Resistant Obsessive Compulsive Disorder: A Randomized, Single-Blind Clinical Trial.Medicina (Kaunas). 2025 Jan 21;61(2):169. doi: 10.3390/medicina61020169. Medicina (Kaunas). 2025. PMID: 40005287 Free PMC article. Clinical Trial.
-
Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial.Brain Stimul. 2019 Jul-Aug;12(4):922-929. doi: 10.1016/j.brs.2019.02.005. Epub 2019 Feb 13. Brain Stimul. 2019. PMID: 30808612 Clinical Trial.
-
Transcranial direct current stimulation for obsessive-compulsive disorder: A randomized, controlled, partial crossover trial.Depress Anxiety. 2016 Dec;33(12):1132-1140. doi: 10.1002/da.22578. Epub 2016 Nov 1. Depress Anxiety. 2016. PMID: 27802585 Clinical Trial.
-
Transcranial cortical stimulation in the treatment of obsessive-compulsive disorders: efficacy studies.Curr Psychiatry Rep. 2015 May;17(5):36. doi: 10.1007/s11920-015-0571-3. Curr Psychiatry Rep. 2015. PMID: 25825002 Review.
-
Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review.Curr Neuropharmacol. 2019;17(8):787-807. doi: 10.2174/1570159X17666190409142555. Curr Neuropharmacol. 2019. PMID: 30963971 Free PMC article.
Cited by
-
Treating refractory obsessive compulsive disorder with cathodal transcranial direct current stimulation over the supplementary motor area: a large multisite randomized sham-controlled double-blind study.Front Psychiatry. 2024 May 17;15:1338594. doi: 10.3389/fpsyt.2024.1338594. eCollection 2024. Front Psychiatry. 2024. PMID: 38827437 Free PMC article.
-
Comparing Different Montages of Transcranial Direct Current Stimulation in Treating Treatment-Resistant Obsessive Compulsive Disorder: A Randomized, Single-Blind Clinical Trial.Medicina (Kaunas). 2025 Jan 21;61(2):169. doi: 10.3390/medicina61020169. Medicina (Kaunas). 2025. PMID: 40005287 Free PMC article. Clinical Trial.
-
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial.BMC Psychiatry. 2023 Sep 21;23(1):686. doi: 10.1186/s12888-023-05189-7. BMC Psychiatry. 2023. PMID: 37735631 Free PMC article. Clinical Trial.
-
Insight in obsessive-compulsive disorder: conception, clinical characteristics, neuroimaging, and treatment.Psychoradiology. 2023 Nov 8;3:kkad025. doi: 10.1093/psyrad/kkad025. eCollection 2023. Psychoradiology. 2023. PMID: 38666121 Free PMC article. Review.
-
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD).Pilot Feasibility Stud. 2021 Dec 6;7(1):213. doi: 10.1186/s40814-021-00945-6. Pilot Feasibility Stud. 2021. PMID: 34872621 Free PMC article.
References
-
- Bation, R. , Mondino, M. , Le Camus, F. , Saoud, M. , & Brunelin, J. (2019). Transcranial direct current stimulation in patients with obsessive compulsive disorder: A Randomized Controlled Trial. European Psychiatry: The Journal of the Association of European Psychiatrists, 62, 38–44. - PubMed
-
- Brunoni, A. R. , Amadera, J. , Berbel, B. , Volz, M. S. , Rizzerio, B. G. , & Fregni, F. (2011). A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. The International Journal of Neuropsychopharmacology, 14(8), 1133–1145. 10.1017/S1461145710001690 - DOI - PubMed
-
- Brunoni, A. R. , Valiengo, L. , Baccaro, A. , Zanão, T. A. , de Oliveira, J. F. , Goulart, A. , … Fregni, F. (2013). « The sertraline vs. electrical current therapy for treating depression clinical study: Results from a factorial, Randomized, Controlled Trial. JAMA Psychiatry, 70(4), 383–391. 10.1001/2013.jamapsychiatry.32 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical